|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,499.00 JPY | -4.22% |
|
+6.18% | +12.85% |
| 01-28 | Tech Outlook, Shaky US Dollar Lift Asian Stock Markets | MT |
| 01-28 | Japan's Nikkei escapes losses as tech share gains offset drag from strong yen | RE |
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 7.42 | 11.31 | 14.21 | 8.87 | 8.6 | |||||
Return on Total Capital | 8.66 | 13.19 | 16.6 | 10.3 | 9.97 | |||||
Return On Equity % | 10.67 | 16.63 | 20.48 | 13.38 | 12.53 | |||||
Return on Common Equity | 10.74 | 16.28 | 19.66 | 12.78 | 11.97 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 36.32 | 41.84 | 43.22 | 37.73 | 38.42 | |||||
SG&A Margin | 9.98 | 9.1 | 7.59 | 8.47 | 9.18 | |||||
EBITDA Margin % | 35.81 | 40.56 | 43.14 | 38.45 | 38.28 | |||||
EBITA Margin % | 26.2 | 32.43 | 35.54 | 29.03 | 28.97 | |||||
EBIT Margin % | 26.2 | 32.43 | 35.54 | 29.03 | 28.97 | |||||
Income From Continuing Operations Margin % | 19.99 | 25.31 | 27.19 | 23.4 | 22.65 | |||||
Net Income Margin % | 19.62 | 24.11 | 25.21 | 21.54 | 20.85 | |||||
Net Avail. For Common Margin % | 19.62 | 24.11 | 25.21 | 21.54 | 20.85 | |||||
Normalized Net Income Margin | 16.63 | 19.81 | 20.84 | 18.57 | 18.33 | |||||
Levered Free Cash Flow Margin | 7.2 | 12.75 | 10.99 | 10.21 | 7.65 | |||||
Unlevered Free Cash Flow Margin | 7.23 | 12.75 | 11.02 | 10.25 | 7.65 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.45 | 0.56 | 0.64 | 0.49 | 0.47 | |||||
Fixed Assets Turnover | 1.31 | 1.69 | 2 | 1.48 | 1.34 | |||||
Receivables Turnover (Average Receivables) | 4.56 | 5.15 | 6.01 | 5.13 | 5.23 | |||||
Inventory Turnover (Average Inventory) | 2.61 | 2.95 | 2.79 | 2.13 | 2.12 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 5.27 | 5.1 | 5.64 | 5.84 | 5.98 | |||||
Quick Ratio | 4.1 | 3.98 | 4.07 | 4.22 | 4.31 | |||||
Operating Cash Flow to Current Liabilities | 1.1 | 1.16 | 1.55 | 1.45 | 1.64 | |||||
Days Sales Outstanding (Average Receivables) | 80 | 70.87 | 60.72 | 71.35 | 69.79 | |||||
Days Outstanding Inventory (Average Inventory) | 139.9 | 123.85 | 130.71 | 171.49 | 172.49 | |||||
Average Days Payable Outstanding | 50.17 | 42.71 | 36.18 | 41.27 | 38.79 | |||||
Cash Conversion Cycle (Average Days) | 169.73 | 152 | 155.25 | 201.57 | 203.49 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 0.96 | 0.89 | 0.74 | 0.55 | 0.35 | |||||
Total Debt / Total Capital | 0.95 | 0.88 | 0.73 | 0.55 | 0.35 | |||||
LT Debt/Equity | 0.55 | 0.49 | 0.47 | 0.31 | 0.15 | |||||
Long-Term Debt / Total Capital | 0.55 | 0.49 | 0.46 | 0.31 | 0.15 | |||||
Total Liabilities / Total Assets | 14.61 | 15.4 | 14.89 | 14.06 | 14.18 | |||||
EBIT / Interest Expense | 538.76 | - | 669.93 | 467.05 | - | |||||
EBITDA / Interest Expense | 736.29 | - | 813.31 | 618.69 | - | |||||
(EBITDA - Capex) / Interest Expense | 411.85 | - | 614.98 | 369.25 | - | |||||
Total Debt / EBITDA | 0.05 | 0.04 | 0.02 | 0.03 | 0.02 | |||||
Net Debt / EBITDA | -2.1 | -1.67 | -1.3 | -1.83 | -1.83 | |||||
Total Debt / (EBITDA - Capex) | 0.09 | 0.05 | 0.03 | 0.04 | 0.03 | |||||
Net Debt / (EBITDA - Capex) | -3.75 | -2.18 | -1.71 | -3.06 | -3.32 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -3.02 | 38.58 | 35.4 | -14.02 | 6.06 | |||||
Gross Profit, 1 Yr. Growth % | -2.17 | 59.65 | 39.87 | -24.95 | 8 | |||||
EBITDA, 1 Yr. Growth % | -0.22 | 56.98 | 44.01 | -23.37 | 5.58 | |||||
EBITA, 1 Yr. Growth % | -3.41 | 71.51 | 48.39 | -29.77 | 5.86 | |||||
EBIT, 1 Yr. Growth % | -3.41 | 71.51 | 48.39 | -29.77 | 5.86 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -6.01 | 75.49 | 45.44 | -25.99 | 2.64 | |||||
Net Income, 1 Yr. Growth % | -6.46 | 70.26 | 41.61 | -26.56 | 2.67 | |||||
Normalized Net Income, 1 Yr. Growth % | -3.18 | 65.03 | 42.46 | -23.39 | 4.69 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -6.46 | 70.3 | 44.51 | -25.45 | 3.91 | |||||
Accounts Receivable, 1 Yr. Growth % | 6.15 | 38.43 | -0.18 | 1.69 | 6.32 | |||||
Inventory, 1 Yr. Growth % | -0.17 | 24.28 | 51.76 | 4.67 | 6.84 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 4.04 | 10.73 | 17.67 | 15.04 | 18.29 | |||||
Total Assets, 1 Yr. Growth % | 4.65 | 19.9 | 16.7 | 8.83 | 9.49 | |||||
Tangible Book Value, 1 Yr. Growth % | 6.13 | 18.26 | 16.42 | 10.06 | 8.77 | |||||
Common Equity, 1 Yr. Growth % | 6.06 | 18.26 | 16.37 | 10.03 | 9.38 | |||||
Cash From Operations, 1 Yr. Growth % | -2.72 | 37.98 | 42.36 | -4.17 | 16.78 | |||||
Capital Expenditures, 1 Yr. Growth % | -11.99 | -17.11 | 50.95 | 26.7 | 17.38 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 51.07 | 145.43 | 16.7 | -20.12 | -20.58 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 50.72 | 144.4 | 17.05 | -20.06 | -20.89 | |||||
Dividend Per Share, 1 Yr. Growth % | 13.64 | 60 | 25 | 0 | 6 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -3.09 | 15.93 | 36.98 | 7.9 | -4.51 | |||||
Gross Profit, 2 Yr. CAGR % | -0.94 | 24.98 | 49.43 | 2.46 | -9.97 | |||||
EBITDA, 2 Yr. CAGR % | -0.49 | 25.15 | 50.36 | 5.05 | -10.05 | |||||
EBITA, 2 Yr. CAGR % | -1.43 | 28.71 | 59.53 | 2.09 | -13.78 | |||||
EBIT, 2 Yr. CAGR % | -1.43 | 28.71 | 59.53 | 2.09 | -13.78 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -2.39 | 28.43 | 59.76 | 3.75 | -12.84 | |||||
Net Income, 2 Yr. CAGR % | -2.52 | 26.2 | 55.28 | 1.98 | -13.17 | |||||
Normalized Net Income, 2 Yr. CAGR % | -1.64 | 26.41 | 53.33 | 4.47 | -10.45 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -1.36 | 26.21 | 56.87 | 3.79 | -11.99 | |||||
Accounts Receivable, 2 Yr. CAGR % | 0.98 | 21.22 | 17.55 | 0.75 | 3.98 | |||||
Inventory, 2 Yr. CAGR % | 5.25 | 11.38 | 37.33 | 26.04 | 5.75 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 8.6 | 7.33 | 14.15 | 16.35 | 16.65 | |||||
Total Assets, 2 Yr. CAGR % | 5.48 | 12.02 | 18.29 | 12.7 | 9.16 | |||||
Tangible Book Value, 2 Yr. CAGR % | 6.85 | 12.03 | 17.34 | 13.2 | 9.41 | |||||
Common Equity, 2 Yr. CAGR % | 6.83 | 12 | 17.31 | 13.15 | 9.7 | |||||
Cash From Operations, 2 Yr. CAGR % | 0.06 | 15.86 | 40.15 | 16.8 | 5.79 | |||||
Capital Expenditures, 2 Yr. CAGR % | 2.06 | -14.59 | 11.86 | 38.29 | 21.95 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -15.14 | 92.56 | 69.24 | -3.45 | -20.35 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -15.1 | 91.93 | 69.13 | -3.27 | -20.47 | |||||
Dividend Per Share, 2 Yr. CAGR % | 11.8 | 34.84 | 41.42 | 11.8 | 2.96 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 1.27 | 9.18 | 22.09 | 17.28 | 7.28 | |||||
Gross Profit, 3 Yr. CAGR % | 4.36 | 16.14 | 29.76 | 18.78 | 4.27 | |||||
EBITDA, 3 Yr. CAGR % | 6.1 | 15.84 | 31.15 | 20.1 | 5.23 | |||||
EBITA, 3 Yr. CAGR % | 5.21 | 18.55 | 34.96 | 21.36 | 3.33 | |||||
EBIT, 3 Yr. CAGR % | 5.21 | 18.55 | 34.96 | 21.36 | 3.33 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 3.47 | 18.69 | 33.87 | 23.62 | 3.38 | |||||
Net Income, 3 Yr. CAGR % | 3.33 | 17.39 | 31.14 | 20.98 | 2.21 | |||||
Normalized Net Income, 3 Yr. CAGR % | 5.69 | 16.88 | 31.55 | 21.67 | 4.54 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 4.21 | 18.33 | 32.04 | 22.42 | 3.83 | |||||
Accounts Receivable, 3 Yr. CAGR % | 1.76 | 12.18 | 13.62 | 12.01 | 2.57 | |||||
Inventory, 3 Yr. CAGR % | 8.97 | 11.25 | 23.48 | 25.45 | 19.28 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 9 | 9.3 | 10.67 | 14.45 | 16.99 | |||||
Total Assets, 3 Yr. CAGR % | 5.14 | 10.08 | 13.56 | 15.05 | 11.62 | |||||
Tangible Book Value, 3 Yr. CAGR % | 6.21 | 10.53 | 13.48 | 14.86 | 11.7 | |||||
Common Equity, 3 Yr. CAGR % | 6.18 | 10.51 | 13.44 | 14.83 | 11.88 | |||||
Cash From Operations, 3 Yr. CAGR % | 6.43 | 11.37 | 24.09 | 23.47 | 16.8 | |||||
Capital Expenditures, 3 Yr. CAGR % | 13.32 | -4.78 | 3.26 | 16.6 | 30.94 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -10.95 | 20.9 | 62.95 | 31.77 | -9.54 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -10.9 | 20.78 | 62.76 | 31.75 | -9.54 | |||||
Dividend Per Share, 3 Yr. CAGR % | 21.32 | 25.99 | 31.48 | 25.99 | 9.83 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 3.18 | 10.89 | 14.27 | 8.66 | 10.66 | |||||
Gross Profit, 5 Yr. CAGR % | 9.22 | 18.66 | 20.47 | 10.46 | 12.11 | |||||
EBITDA, 5 Yr. CAGR % | 11.65 | 20.46 | 21.97 | 11.4 | 12.79 | |||||
EBITA, 5 Yr. CAGR % | 13.47 | 23.03 | 24.27 | 11.67 | 12.82 | |||||
EBIT, 5 Yr. CAGR % | 13.47 | 23.03 | 24.27 | 11.67 | 12.82 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 14.75 | 24.11 | 23.11 | 12.47 | 12.76 | |||||
Net Income, 5 Yr. CAGR % | 14.56 | 23.24 | 21.61 | 10.97 | 11.2 | |||||
Normalized Net Income, 5 Yr. CAGR % | 12.72 | 22.4 | 22.65 | 11.75 | 12.79 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 15.11 | 23.85 | 22.73 | 12.28 | 12.26 | |||||
Accounts Receivable, 5 Yr. CAGR % | 5.87 | 11.34 | 7.8 | 7.46 | 9.66 | |||||
Inventory, 5 Yr. CAGR % | 5.37 | 11.17 | 19.54 | 16.94 | 16.06 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 7.68 | 8.79 | 11.03 | 12.07 | 13.03 | |||||
Total Assets, 5 Yr. CAGR % | 6.14 | 8.83 | 10.22 | 11.12 | 11.78 | |||||
Tangible Book Value, 5 Yr. CAGR % | 6.84 | 9.35 | 10.53 | 11.59 | 11.83 | |||||
Common Equity, 5 Yr. CAGR % | 6.77 | 9.31 | 10.5 | 11.56 | 11.93 | |||||
Cash From Operations, 5 Yr. CAGR % | 7.33 | 13.73 | 18.82 | 13.51 | 16.42 | |||||
Capital Expenditures, 5 Yr. CAGR % | 9.91 | 7.73 | 12.73 | 10.55 | 10.37 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 6.25 | 12.86 | 15.13 | 10.5 | 22.38 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 6.27 | 12.81 | 15.14 | 10.51 | 22.22 | |||||
Dividend Per Share, 5 Yr. CAGR % | 17.84 | 27.23 | 28.99 | 20.11 | 19.23 |
- Stock Market
- Equities
- 4063 Stock
- Financials Shin-Etsu Chemical Co., Ltd.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















